SCHEMBL4895677

SCHEMBL4895677

Cc1cc(S(=O)(=O)NCCSc2ccc(Oc3ccc4ccccc4c3)cc2)cc(C(=O)O)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.46
MAPT P10636 1/20 0.43
TSHR P16473 3/20 0.43
HSD17B10 Q99714 2/20 0.43
BCL2 P10415 1/20 0.42
BCL2L1 Q07817 1/20 0.42
MCL1 Q07820 1/20 0.42
BCL2A1 Q16548 1/20 0.42
LMNA P02545 3/20 0.41
GAA P10253 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HTT P42858 1/20 0.40
HRAS P01112 1/20 0.40
KRAS P01116 1/20 0.40
CYP2C9 P11712 3/20 0.40
CYP1A2 P05177 2/20 0.40
PLA2G7 Q13093 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902759 0.92 ALDH1A1 (0.43) ALDH1A1MAPTTSHRHSD17B10BCL2
SCHEMBL4904421 0.90 ALDH1A1 (0.43) ALDH1A1MAPTTSHRHSD17B10LMNA
SCHEMBL4907418 0.89 ALDH1A1 (0.51) ALDH1A1MAPTTSHRHSD17B10LMNA
SCHEMBL4905851 0.89 ALDH1A1 (0.47) ALDH1A1MAPTTSHRHSD17B10LMNA
SCHEMBL4908214 0.88 ALDH1A1 (0.54) ALDH1A1MAPTTSHRHSD17B10LMNA
SCHEMBL4903961 0.88 BCL2L1 (0.45) ALDH1A1MAPTTSHRHSD17B10BCL2
SCHEMBL4906804 0.87 ALDH1A1 (0.44) ALDH1A1MAPTTSHRHSD17B10LMNA
SCHEMBL4902542 0.87 ALDH1A1 (0.43) ALDH1A1MAPTTSHRHSD17B10LMNA
SCHEMBL4906147 0.87 ALDH1A1 (0.45) ALDH1A1MAPTTSHRHSD17B10LMNA
SCHEMBL4902687 0.86 ALDH1A1 (0.45) ALDH1A1MAPTTSHRHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885MAPT 1786/4885TSHR 400/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885MAPT 1786/4885TSHR 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.